Name: Latest research reports of Wipro Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Wipro Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	17 Apr 2025	Wipro	BOB Capital Markets Ltd. Target	249.85	242.00	236.90 (5.47%)	Target met	Hold	pdf post cache	Broker Report Wipro (HOLD): Weak 1QFY26 signals a third year of revenue decline BOB Capital Markets Ltd. Uncertainty hit 4QFY25 and led to weaker 1QFY26 guidance. A quick tariff resolution required to avert a third successive revenue decline pdf Copy Link Share on Share on Share on Share on Alert
	16 Apr 2025	ICICI Prudential	BOB Capital Markets Ltd. Reco Target	663.30	674.00	586.30 (13.13%)	Target met	Buy	pdf post cache	Broker Report ICICI Prudential Life (BUY): APE declines, margin expands BOB Capital Markets Ltd. APE declines 3% YoY Q4FY25 vs our expectation of moderate growth, grew 15% YoY in FY25 pdf Copy Link Share on Share on Share on Share on Alert
	11 Apr 2025	Abbott	BOB Capital Markets Ltd.	30345.00	35292.00	29641.10 (2.37%)	16.30	Buy	pdf post cache	Broker Report [Initiation] Abbott India (BUY): A safe pick amidst tariff woes BOB Capital Markets Ltd. Sales expected to reach USD 1bn, driven by industry-leading MR productivity of Rs 14.9mn by FY27E from Rs 11.5mn in FY24 pdf Copy Link Share on Share on Share on Share on Alert
	11 Apr 2025	TCS	BOB Capital Markets Ltd. Target	3490.80	3072.00	3231.50 (8.02%)	-12.00	Hold	pdf post cache	Broker Report Tata Consultancy Services (HOLD): FY26>FY25 is unambitious BOB Capital Markets Ltd. Weak start for FY26 likely. Salary hike postponed due to uncertainty in the demand environment pdf Copy Link Share on Share on Share on Share on Alert
	28 Mar 2025	Equitas Small Finance Bank	BOB Capital Markets Ltd.	63.18	73.00	54.98 (14.91%)	15.54	Buy	pdf post cache	Broker Report [Initiation] Equitas Small Finance Bank: De-risked portfolio growth; available at a discount BOB Capital Markets Ltd. Rising share of diversified and secured portfolio with MFI mix likely to decline further; scaling up granular deposit franchise pdf Copy Link Share on Share on Share on Share on Alert
	24 Mar 2025	Cohance Lifesciences	BOB Capital Markets Ltd.	1068.90	1405.00	1175.50 (-9.07%)	31.44	Buy	pdf post cache	Broker Report [Initiation] A play on the ADC growth segment BOB Capital Markets Ltd. ADC is an evolving second line of treatment in oncology. The company expects market size to grow to US$ 50bn by FY33 from US$ 5bn in FY22 pdf Copy Link Share on Share on Share on Share on Alert
	21 Mar 2025	Software & Services	BOB Capital Markets Ltd.					Not Rated	pdf post cache	Broker Report Accenture (NOT RATED): Significant deceleration on the cards. Unsure if worst is over BOB Capital Markets Ltd. YoY organic growth is expected to decelerate from ~4.5% in 2QFY25 to 0.5% in 4Q. Implies a US$2.6bn annualized organic revenue loss pdf Copy Link Share on Share on Share on Share on Alert
	17 Mar 2025	Aurobindo Pharma	BOB Capital Markets Ltd. Reco Target	1155.40	1451.00	1111.70 (3.93%)	25.58	Buy	pdf post cache	Broker Report Aurobindo Pharma (BUY): Growth triggers intact; valuations attractive BOB Capital Markets Ltd. Eugia unit 3 capacity utilization to increase to 60-65% from 50% in Q3FY25. We expect capacity utilisation to rise above 70% in FY26E pdf Copy Link Share on Share on Share on Share on Alert
	11 Mar 2025	IndusInd Bank	BOB Capital Markets Ltd. Reco Target	814.95	870.00	655.95 (24.24%)	6.76	Hold	pdf post cache	Broker Report IndusInd Bank (HOLD): Net worth impact led by accounting discrepancy; HOLD BOB Capital Markets Ltd. Discrepancy in derivative portfolio account to adversely impact net worth by 2.35%, indicates weak internal controls pdf Copy Link Share on Share on Share on Share on Alert
	11 Mar 2025	Supreme Industries	BOB Capital Markets Ltd. Target	4196.70	5150.00	3333.95 (25.88%)	22.72	Buy	pdf post cache	Broker Report Supreme Industries (BUY): Wavin acquisition to bolster SI's market share and return ratios BOB Capital Markets Ltd. Wavin acquisition will enable SI to gain market share in North and South India pdf Copy Link Share on Share on Share on Share on Alert
more loading

BOB Capital Markets Ltd. Broker Research reports

Latest broker research reports from BOB Capital Markets Ltd. buy, sell, hold, neutral recommendations along with share price targets forecast and upside.

Wipro (HOLD): Weak 1QFY26 signals a third year of revenue decline

ICICI Prudential Life (BUY): APE declines, margin expands

[Initiation] Abbott India (BUY): A safe pick amidst tariff woes

Tata Consultancy Services (HOLD): FY26>FY25 is unambitious

[Initiation] Equitas Small Finance Bank: De-risked portfolio growth; available at a discount

[Initiation] A play on the ADC growth segment

Accenture (NOT RATED): Significant deceleration on the cards. Unsure if worst is over

Aurobindo Pharma (BUY): Growth triggers intact; valuations attractive

IndusInd Bank (HOLD): Net worth impact led by accounting discrepancy; HOLD

Supreme Industries (BUY): Wavin acquisition to bolster SI's market share and return ratios

Advisor Screeners